ARTICLE | Company News
GlaxoSmithKline autoimmune news
May 25, 2009 7:00 AM UTC
GlaxoSmithKline created a research unit in Cambridge, Mass., to discover small molecule drug candidates targeting regulatory T cells and T helper type 17 (Th17) effector cells for autoimmune diseases....